SecurityCNSX:LXX / Lexaria Bioscience Corp.
CEOBUNKA CHRISTOPHER
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners0
Common Shares Outstanding73,144,805 shares (as of 2018-05-31)

Institutional Stock Ownership and Shareholders

Lexaria Bioscience Corp. (CNSX:LXX) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
Lexaria Bioscience Corp. (CNSX:LXX) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Important Note!
Note: We do not currently have a CUSIP on file for this security. That means we are unable to search institutional fund filings (13F's) for this company, which means there may be institutional holders that we are unaware of. If you know the CUSIP or would like us to research and update this security, please let us know by leaving a message in the Welcome Group.
File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)

Related News Stories

Lexaria Bioscience: DehydraTECH Could Transform Oral Delivery In Cannabis, Nicotine, NSAIDs, And Vitamins

2018-10-18 seekingalpha
Lexaria Bioscience is a growing company whose DehydraTECH could be revolutionary in improving the delivery of active pharmaceutical ingredients. (2-0)

Lexaria Bioscience Receives Two New Granted Patents

2018-10-18 accesswire
KELOWNA, BC / ACCESSWIRE / October 18, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has been granted two new US patents. (2-0)

30 Marijuana Stocks to Buy as the Future Turns Green

2018-10-17 investorplace
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. (38-4)

Lexaria Files New Patent Application for Delivery of Tobacco-Derived Products

2018-09-28 accesswire
KELOWNA, BC / ACCESSWIRE / September 28, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the filing of a new strategic patent application. (2-0)

UPDATE: OTC Markets Group Announces Agenda for OTCQX Virtual Investor Conference on October 4

2018-09-26 accesswire
NEW YORK, NY / ACCESSWIRE / September 26, 2018 / OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the agenda for its upcoming OTCQX® Virtual Investor Conference, on October 4, 2018, featuring US-based issuers traded on the OTCQX Best Market. (2-0)